Section 5. Breast: Overview: Current status of breast conserving therapy in Japan

Tadashi Ikeda, Hiromitsu Jinno, Akira Matsui, Yoko Mitsui, Sota Asaga, Tsuyoshi Mutoh, Masahiro Wada, Masaki Kitajima

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Breast conserving operations have become the standard operation for early breast cancer. They were performed in about 40% of all breast cancer patients in Japan in 2000, and the percentage is still increasing. Ductal carcinoma in situ (DCIS) accounts for about 7% of all breast cancers and breast conserving operations for DCIS have been followed by a low in-breast recurrence rate, leading to wider indications for breast conserving operations as screening mammography has come to be used in Japan. In-breast recurrence is correlated to surgical margin status. It is important to evaluate the surgical margin for volume of cancer cell nests as well as for positivity. Neoadjuvant chemotherapy has become popular as an in vivo sensitivity test and as a means of down-staging to increase the possibility of performing a breast conserving operation. There are two patterns of shrinkage when neoadjuvant chemotherapy is effective: cocentric and honeycomb, and the pattern of residual cancer cell nests must be determined before surgery. MRI is an effective method of evaluating residual cancer cell nests. The in-breast recurrence rate after down-staging to perform breast conserving operations is reported to be higher than among candidates for breast conserving operation at the start. Sentinel node biopsy techniques and endoscopic operations are now being assessed in conjunction with breast conserving operations. The current status of breast conserving operations in Japan is reviewed in comparison with their status in Western countries.

Original languageEnglish
JournalBiomedicine and Pharmacotherapy
Volume56
Issue numberSUPPL. 1
Publication statusPublished - 2002 Nov

Fingerprint

Japan
Breast
Breast Neoplasms
Therapeutics
Carcinoma, Intraductal, Noninfiltrating
Residual Neoplasm
Recurrence
Drug Therapy
Mammography
Cell Size
Biopsy
Neoplasms

Keywords

  • Breast cancer
  • Breast conserving operation
  • Japan

ASJC Scopus subject areas

  • Pharmacology

Cite this

Ikeda, T., Jinno, H., Matsui, A., Mitsui, Y., Asaga, S., Mutoh, T., ... Kitajima, M. (2002). Section 5. Breast: Overview: Current status of breast conserving therapy in Japan. Biomedicine and Pharmacotherapy, 56(SUPPL. 1).

Section 5. Breast : Overview: Current status of breast conserving therapy in Japan. / Ikeda, Tadashi; Jinno, Hiromitsu; Matsui, Akira; Mitsui, Yoko; Asaga, Sota; Mutoh, Tsuyoshi; Wada, Masahiro; Kitajima, Masaki.

In: Biomedicine and Pharmacotherapy, Vol. 56, No. SUPPL. 1, 11.2002.

Research output: Contribution to journalArticle

Ikeda, T, Jinno, H, Matsui, A, Mitsui, Y, Asaga, S, Mutoh, T, Wada, M & Kitajima, M 2002, 'Section 5. Breast: Overview: Current status of breast conserving therapy in Japan', Biomedicine and Pharmacotherapy, vol. 56, no. SUPPL. 1.
Ikeda T, Jinno H, Matsui A, Mitsui Y, Asaga S, Mutoh T et al. Section 5. Breast: Overview: Current status of breast conserving therapy in Japan. Biomedicine and Pharmacotherapy. 2002 Nov;56(SUPPL. 1).
Ikeda, Tadashi ; Jinno, Hiromitsu ; Matsui, Akira ; Mitsui, Yoko ; Asaga, Sota ; Mutoh, Tsuyoshi ; Wada, Masahiro ; Kitajima, Masaki. / Section 5. Breast : Overview: Current status of breast conserving therapy in Japan. In: Biomedicine and Pharmacotherapy. 2002 ; Vol. 56, No. SUPPL. 1.
@article{5fbfc2ceed674273abccda04ebd74df1,
title = "Section 5. Breast: Overview: Current status of breast conserving therapy in Japan",
abstract = "Breast conserving operations have become the standard operation for early breast cancer. They were performed in about 40{\%} of all breast cancer patients in Japan in 2000, and the percentage is still increasing. Ductal carcinoma in situ (DCIS) accounts for about 7{\%} of all breast cancers and breast conserving operations for DCIS have been followed by a low in-breast recurrence rate, leading to wider indications for breast conserving operations as screening mammography has come to be used in Japan. In-breast recurrence is correlated to surgical margin status. It is important to evaluate the surgical margin for volume of cancer cell nests as well as for positivity. Neoadjuvant chemotherapy has become popular as an in vivo sensitivity test and as a means of down-staging to increase the possibility of performing a breast conserving operation. There are two patterns of shrinkage when neoadjuvant chemotherapy is effective: cocentric and honeycomb, and the pattern of residual cancer cell nests must be determined before surgery. MRI is an effective method of evaluating residual cancer cell nests. The in-breast recurrence rate after down-staging to perform breast conserving operations is reported to be higher than among candidates for breast conserving operation at the start. Sentinel node biopsy techniques and endoscopic operations are now being assessed in conjunction with breast conserving operations. The current status of breast conserving operations in Japan is reviewed in comparison with their status in Western countries.",
keywords = "Breast cancer, Breast conserving operation, Japan",
author = "Tadashi Ikeda and Hiromitsu Jinno and Akira Matsui and Yoko Mitsui and Sota Asaga and Tsuyoshi Mutoh and Masahiro Wada and Masaki Kitajima",
year = "2002",
month = "11",
language = "English",
volume = "56",
journal = "Biomedicine and Pharmacotherapy",
issn = "0753-3322",
publisher = "Elsevier Masson",
number = "SUPPL. 1",

}

TY - JOUR

T1 - Section 5. Breast

T2 - Overview: Current status of breast conserving therapy in Japan

AU - Ikeda, Tadashi

AU - Jinno, Hiromitsu

AU - Matsui, Akira

AU - Mitsui, Yoko

AU - Asaga, Sota

AU - Mutoh, Tsuyoshi

AU - Wada, Masahiro

AU - Kitajima, Masaki

PY - 2002/11

Y1 - 2002/11

N2 - Breast conserving operations have become the standard operation for early breast cancer. They were performed in about 40% of all breast cancer patients in Japan in 2000, and the percentage is still increasing. Ductal carcinoma in situ (DCIS) accounts for about 7% of all breast cancers and breast conserving operations for DCIS have been followed by a low in-breast recurrence rate, leading to wider indications for breast conserving operations as screening mammography has come to be used in Japan. In-breast recurrence is correlated to surgical margin status. It is important to evaluate the surgical margin for volume of cancer cell nests as well as for positivity. Neoadjuvant chemotherapy has become popular as an in vivo sensitivity test and as a means of down-staging to increase the possibility of performing a breast conserving operation. There are two patterns of shrinkage when neoadjuvant chemotherapy is effective: cocentric and honeycomb, and the pattern of residual cancer cell nests must be determined before surgery. MRI is an effective method of evaluating residual cancer cell nests. The in-breast recurrence rate after down-staging to perform breast conserving operations is reported to be higher than among candidates for breast conserving operation at the start. Sentinel node biopsy techniques and endoscopic operations are now being assessed in conjunction with breast conserving operations. The current status of breast conserving operations in Japan is reviewed in comparison with their status in Western countries.

AB - Breast conserving operations have become the standard operation for early breast cancer. They were performed in about 40% of all breast cancer patients in Japan in 2000, and the percentage is still increasing. Ductal carcinoma in situ (DCIS) accounts for about 7% of all breast cancers and breast conserving operations for DCIS have been followed by a low in-breast recurrence rate, leading to wider indications for breast conserving operations as screening mammography has come to be used in Japan. In-breast recurrence is correlated to surgical margin status. It is important to evaluate the surgical margin for volume of cancer cell nests as well as for positivity. Neoadjuvant chemotherapy has become popular as an in vivo sensitivity test and as a means of down-staging to increase the possibility of performing a breast conserving operation. There are two patterns of shrinkage when neoadjuvant chemotherapy is effective: cocentric and honeycomb, and the pattern of residual cancer cell nests must be determined before surgery. MRI is an effective method of evaluating residual cancer cell nests. The in-breast recurrence rate after down-staging to perform breast conserving operations is reported to be higher than among candidates for breast conserving operation at the start. Sentinel node biopsy techniques and endoscopic operations are now being assessed in conjunction with breast conserving operations. The current status of breast conserving operations in Japan is reviewed in comparison with their status in Western countries.

KW - Breast cancer

KW - Breast conserving operation

KW - Japan

UR - http://www.scopus.com/inward/record.url?scp=0036861329&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036861329&partnerID=8YFLogxK

M3 - Article

C2 - 12487278

AN - SCOPUS:0036861329

VL - 56

JO - Biomedicine and Pharmacotherapy

JF - Biomedicine and Pharmacotherapy

SN - 0753-3322

IS - SUPPL. 1

ER -